FOLH1 and posterior cortical atrophy: Moreover, since oligo-recurrent PCa represent a heterogenous group of men (BCP, first-time BCR, PSA failure after salvage therapy), we aimed to explore the potential benefit of PSMA-guided MDT as a second-line salvage treatment in patients who already received previous first-line salvage therapies for PSA relapse.